Share This Page
Drug Price Trends for EVEKEO
✉ Email this page to a colleague
Average Pharmacy Cost for EVEKEO
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| EVEKEO 10 MG TABLET | 24338-0026-03 | 7.69289 | EACH | 2025-04-23 |
| EVEKEO 10 MG TABLET | 24338-0026-10 | 7.69289 | EACH | 2025-04-23 |
| EVEKEO 10 MG TABLET | 24338-0026-03 | 7.67595 | EACH | 2025-03-19 |
| EVEKEO 10 MG TABLET | 24338-0026-10 | 7.67595 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Evekeo
Introduction to Evekeo
Evekeo, an amphetamine sulfate medication, was approved by the FDA in 2014 for the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and as a short-term treatment for obesity in select cases[4].
Market Presence and Popularity
Evekeo is part of the CNS stimulants drug class and has a significant presence in the ADHD treatment market. In 2020, prescriptions for amphetamines like Evekeo reached about 2.6 million people in the US, accounting for approximately 13% of all ADHD prescriptions[1].
Cost and Pricing
The cost of Evekeo can vary based on the dosage and whether the brand name or generic version is used.
Brand Name Pricing
- For brand-name Evekeo, the cost of 30 tablets (5 mg or 10 mg) is approximately $261, which translates to around $8.71 per day[2][5].
- In comparison, the cost of 60 tablets of Concerta (a methylphenidate-based medication) can range from $380, making Evekeo potentially more cost-effective for higher dosages[1].
Generic Pricing
- Generic versions of Evekeo are significantly cheaper, with costs ranging from $1.70 to $6.80 per day, depending on the dosage and the quantity purchased[1][5].
Price Trends and Projections
Global Pricing Context
The US pharmaceutical market, including drugs like Evekeo, is characterized by higher prices compared to other regions. In 2022, the average price per unit in the US was 5.5 times higher than in the OECD (excluding the US) and 7.7 times higher than in the rest of the world[3].
Recent Price Changes
Between 2017 and 2022, the average price per unit of drugs in the US increased by 14%, while prices in other OECD countries and the rest of the world decreased by 9% and 7%, respectively[3].
Market Size and Growth
ADHD Market
The ADHD medication market is substantial, with methylphenidate-based medications like Concerta being more widely prescribed than amphetamine-based medications like Evekeo. However, Evekeo still holds a significant share, with 2.6 million prescriptions in the US in 2020[1].
Sales Revenue Trends
The US pharmaceutical market, including ADHD medications, has seen significant growth. Sales revenues for retail and non-retail markets grew by 22% and 26%, respectively, between 2017 and 2022. This trend suggests a robust market for ADHD medications, including Evekeo[3].
Competitive Landscape
Evekeo competes with other ADHD medications such as Concerta (methylphenidate) and Mydayis (mixed amphetamine salts XR). Each of these medications has its own pricing structure and market share.
Comparison with Concerta
Concerta is more widely prescribed, with around 5.8 million prescriptions in the US in 2020, compared to Evekeo's 2.6 million. However, Evekeo can be more cost-effective for higher dosages[1].
Comparison with Mydayis
Mydayis, another amphetamine-based medication, has a similar pricing structure to Evekeo but may be less expensive for certain dosages. The cost of Mydayis can range from $2.30 to $9.30 per day for generic versions[5].
Patient Assistance and Discounts
To make Evekeo more accessible, various patient assistance programs and discount cards are available. For example, the Drugs.com Discount Card can save patients up to 80% on the cost of Evekeo and other prescription medications[2].
Key Takeaways
- Market Share: Evekeo holds a significant share in the ADHD medication market, with 2.6 million prescriptions in the US in 2020.
- Pricing: Brand-name Evekeo costs around $8.71 per day, while generic versions are significantly cheaper, ranging from $1.70 to $6.80 per day.
- Global Context: US prices for Evekeo are higher compared to other regions, with a 14% increase in average price per unit between 2017 and 2022.
- Competitive Landscape: Evekeo competes with Concerta and Mydayis, each with its own pricing and market share.
- Patient Assistance: Various discount programs and patient assistance cards are available to reduce the cost of Evekeo.
FAQs
Q: What is Evekeo used for? A: Evekeo is used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and as a short-term treatment for obesity in select cases[4].
Q: How much does Evekeo cost? A: The cost of Evekeo can range from $8.71 per day for brand-name versions to $1.70 to $6.80 per day for generic versions, depending on the dosage and quantity purchased[1][2][5].
Q: Is Evekeo more expensive than other ADHD medications? A: Evekeo can be more cost-effective for higher dosages compared to some other medications like Concerta, but costs can vary based on the specific medication and dosage[1][5].
Q: Are there any patient assistance programs for Evekeo? A: Yes, various patient assistance programs and discount cards, such as the Drugs.com Discount Card, can help reduce the cost of Evekeo[2].
Q: How does the pricing of Evekeo compare globally? A: The US prices for Evekeo are significantly higher than in other OECD countries and the rest of the world, with a 14% increase in average price per unit between 2017 and 2022[3].
Sources
- Evekeo vs Concerta | Power - Clinical Trials
- Evekeo Prices, Coupons, Copay Cards & Patient Assistance
- ISSUE BRIEF - ASPE
- Evekeo vs. Evekeo ODT: ADHD Medication Information - ADDitude
- Evekeo vs Mydayis | Power - Clinical Trials
More… ↓
